Research Article

Shenmayizhi Formula Combined with Ginkgo Extract Tablets for the Treatment of Vascular Dementia: A Randomized, Double-Blind, Controlled Trial

Table 1

Patients’ baseline characteristics.

SMYZF group (n = 85)Ginkgo group (n = 87) value

Age, years, mean (SD)67.22 (7.12)68.07 (6.83)0.428
Sex, n (%)0.359
 Male39 (46)46 (53)
 Female46 (54)41 (47)
Education level, n (%)0.842
 Below primary7 (8)8 (9)
 Primary36 (42)42 (48)
 Middle school41 (48)36 (41)
 High school or above1 (1)1 (1)
BMI, kg/m2, mean (SD)25.00 (3.57)24.63 (3.34)0.484
Heart rates, median (IQR)70 (64–76)70 (65–76)0.510
Risk factors, n (%)
 Hypertension71 (84)72 (83)0.893
 Diabetes27 (32)23 (26)0.442
 Hyperlipidemia19 (22)14 (16)0.297
 Coronary artery disease9 (11)13 (15)0.393
Scale scores, median (IQR)
 HAMD5 (3–6)5 (3–6)0.820
 HIS9 (8–9)8 (7–10)0.300
 CDR1 (1–1)1 (1–1)0.977
 NIHSS6 (5–7)6 (5–8)0.315
 ADL24 (21–33.5)24 (21–29)0.666

Note: sex, education level, hypertension, diabetes, hyperlipidemia, and coronary heart disease history were analyzed by chi-square test (χ2 test).